Brief: Revive Therapeutics Announces Cannabis Product Derivative Manufacturing And Development Facility
20/06/2019 12:07
June 20 (Reuters) - Revive Therapeutics Ltd RVV.V :
* REVIVE THERAPEUTICS ANNOUNCES CANNABIS PRODUCT DERIVATIVE
MANUFACTURING AND DEVELOPMENT FACILITY
Source text for Eikon: ID:nGNXcgmYMH
Further company coverage: RVV.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure